Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income Taxes (QFR115385USNO)

Observation:

Q2 2024: 22,521 (+ more)  Updated: Sep 10, 2024 9:09 AM CDT
Q2 2024:  22,521  
Q1 2024:  4,613  
Q4 2023:  8,543  
Q3 2023:  33,837  
Q2 2023:  14,184  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates

2017-09-06 2024-09-10
 
Source    

2017-09-06 2024-09-10
 
Release    

2017-09-06 2024-09-10
 
Units    

2017-09-06 2024-09-10
 
Frequency    

2017-09-06 2024-09-10
 
Seasonal Adjustment    

2017-09-06 2024-09-10
 
Notes    

2017-09-06 2024-09-10

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Releases

Tags


Top